{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:40:55Z","timestamp":1760146855370},"reference-count":44,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,12,9]],"date-time":"2009-12-09T00:00:00Z","timestamp":1260316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2010,5]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> The clearance of infectious prions from biologic fluids is usually quantified by bioassays based on intracerebral inoculation of hamsters or mice; these tests are slow, cumbersome, imprecise, and very expensive. In the present study we describe the use of a new and highly sensitive cell culture\u2013based infectivity assay to evaluate the performance of several prion removal prototype filters.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> Five units of 1\u2010 to 2\u2010day\u2010old ABO\u2010compatible human red blood cells (RBCs) in saline\u2010adenine\u2010glucose\u2010mannitol were obtained from an AABB\u2010accredited blood bank. The 5 units were combined to create a homogenous pool. Scrapie\u2010infected mouse brain homogenate of a Rocky Mountain Laboratory strain was added to the pooled RBCs. The pooled RBCs were divided into 300\u2010mL aliquots, which were filtered with either standard leukoreduction filter or four prototypes of prion reduction filter. The levels of prion infectivity in the pre\u2010 and postfiltration samples were measured with a cell culture\u2013based standard scrapie cell assay (SSCA).<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> All the 22\u2010layer prion reduction filters removed prion infectivity below the limit of detection of the SSCA (reduction in prion infectivity \u22652.0 log<jats:sup>10<\/jats:sup>LD<jats:sup>50<\/jats:sup>\/mL) while the 10\u2010layer variant showed some residual infectivity.<\/jats:p><jats:p><jats:bold>CONCLUSIONS:<\/jats:bold> These results demonstrate the utility of a highly sensitive cell culture\u2013based infectivity assay for screening prion reduction filters. The use of this type of in vitro infectivity assay will substantially help expedite the screening and discovery of devices aimed at reducing the risk of variant Creutzfeldt\u2010Jakob disease transmission through blood transfusion.<\/jats:p>","DOI":"10.1111\/j.1537-2995.2009.02525.x","type":"journal-article","created":{"date-parts":[[2009,12,9]],"date-time":"2009-12-09T13:04:00Z","timestamp":1260363840000},"page":"980-988","source":"Crossref","is-referenced-by-count":12,"title":["Evaluation of removal of prion infectivity from red blood cells with prion reduction filters using a new rapid and highly sensitive cell culture\u2013based infectivity assay"],"prefix":"10.1111","volume":"50","author":[{"given":"Samuel O.","family":"Sowemimo\u2010Coker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl A.","family":"Demczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,4,28]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00268.x"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)91958-4"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90068-R"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7252.17"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1101(1999)14:3<135::AID-JCA6>3.0.CO;2-S"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)91412-9"},{"key":"e_1_2_8_8_2","unstructured":"The National Creutzfeldt\u2010Jakob Disease Surveillance Unit.The University of Edinburgh UK: incidence of variant Creutzfeldt\u2010Jakob disease onsets and deaths in the UK (Updated November 2 2009). [cited 2009 Nov 10]. Available from: URL:http:\/\/www.cjd.ed.ac.uk\/"},{"key":"e_1_2_8_9_2","unstructured":"New Zealand Ministry of Health.What is Creutzfeldt\u2010Jakob disease? (Updated May 28 2009). [cited 2009 Nov 10]. Available from: URL:http:\/\/www.moh.govt.nz\/moh.nsf\/indexmh\/cjd"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02719-7"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-83-11-2897"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-152520"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15486-X"},{"issue":"3","key":"e_1_2_8_14_2","article-title":"Fourth case of transfusion\u2010associated variant\u2010CJD infection","volume":"1","author":"Health Protection Agency","year":"2007","journal-title":"Health Protection Agency Report"},{"key":"e_1_2_8_15_2","unstructured":"United Kingdom Spongiform Encephalopathy Advisory Committee (SEAC).Annual Report 1997\u20101998. p.10. Department of Environment Food and Rural Affairs: 3\/04 Page Street London SW1P 4PO England UK. Available from: URL:http:\/\/www.seac.gov.uk\/publicats\/seacrept.pdf"},{"key":"e_1_2_8_16_2","unstructured":"US Food and Drug Administration (FDA).Guidance for industry. Revised preventive measures to reduce the possible risk of transmission of Creutzfeldt\u2014Jakob disease (CJD) and variant Creutzfeldt\u2010Jakob Disease (vCJD) by blood and blood products. US Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research (CBER). January2002. Available from URL:http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/GuidanceComplianceRegulatoryInformation\/Guidances\/Blood\/ucm079711.pdf"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16812-8"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2005.00640.x"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2006.00765.x"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2006.00865.x"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1675487"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.172403799"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M704329200"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5298.402"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05403-4"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.18996-0"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409651102"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-0934(97)02197-6"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/104063870501700601"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410110406"},{"key":"e_1_2_8_31_2","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed J","year":"1938","journal-title":"Am J Hyg"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1834432100"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-234-2_4"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1080\/13550280802105283"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0813342106"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.19.12355-12364.2005"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00341-06"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0710152105"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1086\/588193"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2009.30"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1998.38998408999.x"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0041-1132.2003.00586.x"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1999.39111169.x"},{"key":"e_1_2_8_44_2","first-page":"36","volume-title":"WHO guidelines on tissue infectivity distribution in transmissible spongiform encephalopathies","author":"World Health Organization","year":"2006"},{"key":"e_1_2_8_45_2","unstructured":"BlancoAR McCutcheonS De WolfC TanBC HunterN HornseyV ProwseC TurnerM HoustonEF MansonJ.The effect of leucodepletion on transmission of BSE by transfusion of sheep blood components. Prion 2009\u2014Transmissible Spongiform Encephalopathies Meeting September 23\u201025 2009 Thessaloniki\u2010Chalkidiki Greece."}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2009.02525.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2009.02525.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T04:38:37Z","timestamp":1697258317000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2009.02525.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,28]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["10.1111\/j.1537-2995.2009.02525.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2009.02525.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,28]]}}}